Enanta Pharmaceuticals
ENTA
#7360
Rank
A$0.67 B
Marketcap
A$23.27
Share price
5.92%
Change (1 day)
147.53%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.32 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30A$0.35 B-6.18%
2023-09-30A$0.38 B354.35%
2022-09-30A$84.07 M54.45%
2021-09-30A$54.43 M27.68%
2020-09-30A$42.63 M5.31%
2019-09-30A$40.48 M42.31%
2018-09-30A$28.44 M-10.6%
2017-09-30A$31.81 M114.27%
2016-09-30A$14.84 M5.61%
2015-09-30A$14.05 M81.7%
2014-09-30A$7.73 M10.87%
2013-09-30A$6.97 M-12.22%
2012-09-30A$7.95 M86.99%
2011-09-30A$4.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
A$206.36 B 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$171.65 B 52,460.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$11.40 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$117.38 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$118.36 B 36,142.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.54 B 28,850.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland